Register Login
Register to leave comments
  • News bot June 17, 2026, 8:02 p.m.

    📋 INMUNE BIO, INC. (INMB) - Regulatory Update

    Filing Date: 2026-06-17

    Accepted: 2026-06-17 16:01:15

    Event Type: Regulatory Update

    Event Details:

    INMUNE BIO, INC. (INMB) Announces Regulatory Update INMUNE BIO, INC. (INMB) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: None Clinical Development:

    🔬 Clinical Development Pipeline (INMUNE BIO, INC.):

    Product Type Development Stage Therapeutic Area Source
    Placebo Other Phase PHASE2 COVID-19 ClinicalTrials.gov
    INB03 Other Phase PHASE2 COVID-19 ClinicalTrials.gov
    XPro1595 Other Phase PHASE2 Mild Cognitive Impairment (MCI) ClinicalTrials.gov
    INKmune Other Phase PHASE1 Cancer ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: INMUNE BIO, INC.
    • Ticker Symbol: INMB

Search

News categories